[PRESS RELEASE]

Launch of a new chemiluminescence immunoassay analyzer “iStar500”-Flexibility Meets AccuracyTokyo, Japan - November 17, 2023 - Medical ＆ Biological Laboratories Co., Ltd. (CEO: Hiroki Ito), a JSR
Life Sciences Company, announced today that it will

release an automated mono-test

chemiluminescence immunoassay (CLIA) analyzer “iStar 500” worldwide.
The iStar is a highly automated mono-test analyzer based on CLIA technology. The compact andintegrated design, combined with highly sensitive CLIA technology, makes it an ideal choice foremergency diagnosis or small- to medium-sized labs looking for accurate testing results.
The bench top CLIA analyzer offers a wide range of testing parameters including cardiac markers,
reproductive health, liver health, tumor markers and autoimmunity.
For cardiac biomarkers, whole blood is an analyte for measuring the markers and allows
healthcare professionals to make timely and informed decisions for patients. MBL is proud tooffer excellent assay performance for whole blood type cardiac biomarkers in the world withJapan quality.
Images of the iStar 500

Front* Images may differ in appearance from the actual product.

SideTest Panels:
Cardiac Marker

Reproductive HealthThyroid

Autoimmunity

Tumor Marker

MyoProlactin

TSH

ANA

PG 1

CK-MB

E2

FT4

dsDNA

PG 2

cTnI

LH

FT3

Anti-CCP

Gastrin 17

hs-cTnI

Testosterone

T4

RF

CEA

NT-proBNP

Progesterone

T3

tTg IgG

AFP

D-Dimer

FSHTg

tTg IgA

CA 125HCY

HCG

Anti-Tg

DGP IgG

CA 15-3

AnemiaAMH

Anti-TPO

DGP IgA

CA 19-9FerritinInhibin B

Anti-TSHR

GADA

PSA

Vitamin B12SHBG

Inflammation

IAA

fPSA

Folate

DHEA-S

PCTIA-2A

AFP-L3%GrowthLiver Health

IL-6

ICA

PIVKA-2

hGH

CHI3L1SAA

ZnT8A

Glycometabolism

IGF-1

Allergy

CRP

Bone Metabolism

C-peptide

IGFBP-3

Total IgE

HBP

25-OH Vitamin DInsulin

Specifications:
ModeliStar 500

Detection Principle

Acridinium-ester direct chemiluminescence

Throughput

36 T/HTime to first result

11 mins

Auto Sampling Position

5Sample Types

Whole blood, Serum, Plasma, etc.

Sample Volume

5-150 uL

Reagent Position

6×2

Reaction Vessel Capacity

24 × 2

Interface

10.1" build-in touch screen

Incubation Temperature

37.0 ± 0.3°C

Communication Ports

Network port, com port, bi-direction LIS

Dimensions

550 mm(W) × 570 mm(D) × 680 mm(H)Weight55 kg

Contact:
Medical & Biological Laboratories Co., Ltd.
Head Quarter: SUMITOMO FUDOSAN SHIBADAIMON NICHOME BLDG. 2-11-8
Minato-ku, Tokyo

105-0012

Shibadaimon,

Japan

Inquiry: https://www.mblbio.com/e/inq/ivd.html
About Medical & Biological Laboratories Co., Ltd.:
Medical & Biological Laboratories (MBL) was established in 1969 as the first antibody manufacturer inJapan, and researches, develops, manufactures, and sells reagents of in vitro diagnostics (IVD) andreagents for basic research. It has now expanded its business not only to the immunological field but also
to the field of genetic diagnosis.
In the IVD business, we develop and sell IVD reagents for autoimmune diseases, cancer, infectious diseases,etc. Particularly in the field of autoantibody diagnosis, we are expanding our product lineup as a top
manufacturer in Japan and contributing to medical care in this field where there are many intractablediseases. In the field of oncology, we are contributing to personalized medicine by developing companion
diagnostics that predict the effects of drugs.